Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Total Non-Current Liabilities (2020 - 2025)

GoHealth's Total Non-Current Liabilities history spans 6 years, with the latest figure at $805.8 million for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 21.75% year-over-year to $805.8 million; the TTM value through Sep 2025 reached $805.8 million, up 21.75%, while the annual FY2024 figure was $692.0 million, 2.57% up from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $805.8 million at GoHealth, up from $792.1 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.0 billion in Q3 2022 and bottomed at $601.7 million in Q1 2021.
  • The 5-year median for Total Non-Current Liabilities is $761.0 million (2023), against an average of $766.3 million.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 64.75% in 2021 before it fell 24.08% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $959.3 million in 2021, then dropped by 16.38% to $802.1 million in 2022, then dropped by 15.9% to $674.6 million in 2023, then rose by 2.57% to $692.0 million in 2024, then increased by 16.45% to $805.8 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Total Non-Current Liabilities are $805.8 million (Q3 2025), $792.1 million (Q2 2025), and $697.7 million (Q1 2025).